Mark Duman MRPharmS

Salford, England, United Kingdom Contact Info
32K followers 500+ connections

Join to view profile

About

When we really listen to patients and users, we develop products and services that truly…

Articles by Mark

Contributions

Activity

Join now to see all activity

Experience & Education

  • MD Healthcare Consultants

View Mark’s full experience

By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.

Volunteer Experience

  • Novo Nordisk Graphic

    Disease Experience Expert Panels (DEEP) Member

    Novo Nordisk

    - Present 5 years 5 months

    Health

    DEEPs are made up of individuals living with chronic diseases, or relatives of those who are, who can provide disease-specific insights and advice based on their own experiences.
    https://www.novonordisk.com/patients/DEEP.html

  • Google Graphic

    Mentor - GFS Accelerator Europe HealthTech & Wellbeing 2021

    Google

    - Present 3 years

    Health

    Providing patient engagement. digital health and NHS/ UK health market insights to this cohort: thttps://blog.google/outreach-initiatives/entrepreneurs/meet-health-startups-joining-accelerator-europe/

  • GE Healthcare Graphic

    Healthcare Mentor (via Wayra)

    GE Healthcare

    - Present 3 years 1 month

    Health

    Title: Healthcare Mentor
    Organisation: Wayra
    Description: I am delighted to be supporting the next generation of innovators in digital health, because no one person or company can tackle and solve today's healthcare challenges. The future of innovation will be about working across silos and collaborating across the healthcare ecosystem, with start-ups, research centres, hospitals, clinicians and of course, patients. Sharing patient engagement, digital therapeutics and market/ alliance…

    Title: Healthcare Mentor
    Organisation: Wayra
    Description: I am delighted to be supporting the next generation of innovators in digital health, because no one person or company can tackle and solve today's healthcare challenges. The future of innovation will be about working across silos and collaborating across the healthcare ecosystem, with start-ups, research centres, hospitals, clinicians and of course, patients. Sharing patient engagement, digital therapeutics and market/ alliance development insights with this collaborative ecosystem will ideally benefit all of the above.www.ge.com/news/press-releases/ge-healthcare-and-wayra-select-six-ai-led-healthtech-start-ups-for-emea-edisontm

  • Northern Care Alliance NHS Group Graphic

    Public Governor [Salford]

    Northern Care Alliance NHS Group

    - 2 years

    Health

    Holding to Account - To hold the Non- Executive Directors accountable for the work of the Committees in Common and the performance of the Group.
    Representing - To represent the views of the membership, both staff and public members.
    www.pat.nhs.uk/get-involved/council-of-governors.htm

  • Digital Therapeutics Alliance Graphic

    Healthcare Provider / Clinician Advisory Group(s)

    Digital Therapeutics Alliance

    - Present 5 years 7 months

    Health

    Improving healthcare quality, outcomes, and value through optimizing the use and integration of digital therapeutics

  • Diabetes UK Graphic

    North West England Service Champion [Salford]

    Diabetes UK

    - 7 years

    Health

    • Work with the Head of the North and Influencing Manager to look at local diabetes services and identify what’s working well and what needs to be improved.
    • Find out what other people living with diabetes think about/want from local services through mechanisms such as: your local voluntary group; other community organisations; local diabetes planning group; other public involvement forums or local networks; or through email groups.
    • Attend NHS meetings and events as a Diabetes UK…

    • Work with the Head of the North and Influencing Manager to look at local diabetes services and identify what’s working well and what needs to be improved.
    • Find out what other people living with diabetes think about/want from local services through mechanisms such as: your local voluntary group; other community organisations; local diabetes planning group; other public involvement forums or local networks; or through email groups.
    • Attend NHS meetings and events as a Diabetes UK representative. Speaking on behalf of Diabetes UK’s, putting forward views and suggestions on how services could better meet patient’s needs.
    • Work with the Influencing Manager, Volunteer Development Manager, Regional Media Officer, and NHS staff and healthcare professionals to develop plans and objectives to improve local services.
    • Sending feedback to the Head of the North/ Influencing Manager after meetings and events highlighting any issues of concern or any areas you think need to be followed up.
    • Be a positive ambassador for the vision, mission and work of Diabetes UK at all times.

  • PM Society Graphic

    Digital Interest Group (DIG) Steering Group Member

    PM Society

    - Present 5 years 6 months

    Health

    Driving Standards in Digital Marketing
    The PM Society has been driving standards in digital marketing in its broadest sense for several years now, with its annual Digital Awards. The PM Society’s Digital Interest Group aims to go even further in exploring and promoting an understanding of what digital strategies and tactics marketers in the life sciences sector can employ effectively, to support their brand and business.
    Technology is constantly evolving and the more traditional digital…

    Driving Standards in Digital Marketing
    The PM Society has been driving standards in digital marketing in its broadest sense for several years now, with its annual Digital Awards. The PM Society’s Digital Interest Group aims to go even further in exploring and promoting an understanding of what digital strategies and tactics marketers in the life sciences sector can employ effectively, to support their brand and business.
    Technology is constantly evolving and the more traditional digital elements such as e-detailing, animation and DVD are sometimes overlooked in the excitement about the latest trends in social media or apps. The Digital Interest Group is committed to highlighting excellence in all the relevant areas and to helping PM Society members to improve digital competency and share best practice across the industry as interest and uptake increases.

  • Faculty of Pharmaceutical Medicine Graphic

    Strategic Advisory Committee Member

    Faculty of Pharmaceutical Medicine

    - 1 year

    Health

    Pharmaceutical medicine is a medical specialty concerned with the discovery, development, evaluation, licensing and monitoring of medicines and the medical aspects of their marketing. The FPM's members work in diverse environments; from front line clinical trials, to pharmaceutical marketing and medicines regulation.
    Our mission is to advance the science and practice of pharmaceutical medicine by working to develop and maintain competence, ethics and integrity and the highest professional…

    Pharmaceutical medicine is a medical specialty concerned with the discovery, development, evaluation, licensing and monitoring of medicines and the medical aspects of their marketing. The FPM's members work in diverse environments; from front line clinical trials, to pharmaceutical marketing and medicines regulation.
    Our mission is to advance the science and practice of pharmaceutical medicine by working to develop and maintain competence, ethics and integrity and the highest professional standards in the specialty for the benefit of the public. The FPM seeks, through its activities, to bring about an improvement in the health of the public.
    The FPM is a registered charity and therefore ultimately exists for the benefit of patients and the public.

  • NHS England Graphic

    Mentor - Clinical Entrepreneur Training programme

    NHS England

    - Present 7 years 10 months

    Health

    Over the first four years, the programme has recruited over 500 clinical entrepreneurs. Based on metrics collected from the first three years, Clinical Entrepreneurs have raised over £164m of funding, helped return/retain over 106 NHS employees, helped create 1,047 jobs and 175 start-ups, and facilitated over 1,019 partnerships and collaborations. Furthermore, 10,831 organisations have adopted Clinical Entrepreneur innovations, resulting in 17.4m private, professional and patient users of…

    Over the first four years, the programme has recruited over 500 clinical entrepreneurs. Based on metrics collected from the first three years, Clinical Entrepreneurs have raised over £164m of funding, helped return/retain over 106 NHS employees, helped create 1,047 jobs and 175 start-ups, and facilitated over 1,019 partnerships and collaborations. Furthermore, 10,831 organisations have adopted Clinical Entrepreneur innovations, resulting in 17.4m private, professional and patient users of products, processes and

  • Life Science Integrates Graphic

    Steering Committee Member

    Life Science Integrates

    - Present 8 years 5 months

    Health

    Tackling issues such as the rise of precision medicine, disruptive thinking in pharmaceutical regulation, improving patient compliance, future pharmaceutical supply chains and more, key opinion leaders and senior industry stakeholders will debate and discuss the sector’s most pressing challenges and enable life science leaders to stay current and connected in a stimulating peer-to-peer environment.

    The speakers, delegates and sponsors of Pharma Integrates are developers and manufacturers…

    Tackling issues such as the rise of precision medicine, disruptive thinking in pharmaceutical regulation, improving patient compliance, future pharmaceutical supply chains and more, key opinion leaders and senior industry stakeholders will debate and discuss the sector’s most pressing challenges and enable life science leaders to stay current and connected in a stimulating peer-to-peer environment.

    The speakers, delegates and sponsors of Pharma Integrates are developers and manufacturers of pharmaceutical and biopharmaceutical products, specialty chemicals, bulk products and raw materials, drug delivery devices, instrumentation and equipment. They also work in universities, research institutes, government agencies, contract research and manufacturing companies, and organisations involved in consultation and market research, finance, regulatory affairs, information technology and patient advocacy.

  • pro-manchester Graphic

    Healthcare Sector Committee Member

    pro-manchester

    - Present 6 years 6 months

    Health

    Looking at topical issues such as the NHS reform, commissioning teams, development of quality care and NHS efficiency savings, healthcare is a key growth area across the UK. Our programme looks at the initiatives that will need to be considered to keep the region healthy including private sector and social care.

  • Patient Information Forum (PIF) Graphic

    Non Executive Director from Oct13 [previously Co-Founder/ Chair]

    Patient Information Forum (PIF)

    - 20 years 7 months

    Health

    The Patient Information Forum (PIF) is the UK membership organisation and network for people working in, and involved with, healthcare information and support.
    www.pifonline.org.uk

  • The Association of the British Pharmaceutical Industry (ABPI) Graphic

    Patient Organisation Forum (POF) Steering Group Member

    The Association of the British Pharmaceutical Industry (ABPI)

    - 1 year

    Health

    The Patient Organisation Forum has been designed to fulfil the aim of identifying areas of mutual interest, promoting shared understanding and, where appropriate, developing joint working on policy and practice.

  • Department of Health and Social Care Graphic

    Ministerial Industry Strategy Group Medicines Access (Sub) Group Lay Member

    Department of Health and Social Care

    - 4 years

    Health

    A sub-group of the MISG which brings together government and the research-based bio-pharmaceutical industry to look at access to medicines
    www.gov.uk/government/policy-advisory-groups/ministerial-industry-strategy-group

  • The University of Manchester Graphic

    HeRC PPI Strategy Group Member (The FARR Institute)

    The University of Manchester

    - 6 years 4 months

    Science and Technology

    Electronic health research centre (HeRC) will research new ways of harnessing electronic health data to improve care for patients and communities. The consortium brings together partners from academia, the NHS,local authorities and industry in a five to 10-year programme.

  • Dove Medical Press Graphic

    Honorary Editorial Board, Journal of Patient Preference and Adherence

    Dove Medical Press

    - Present 10 years 10 months

    Health

    An international, peer reviewed, open access journal that focuses on the growing importance of patient preference and adherence throughout the therapeutic continuum. The journal is characterized by the rapid reporting of reviews, original research, modeling and clinical studies across all therapeutic areas. Patient satisfaction, acceptability, quality of life, compliance, persistence and their role in developing new therapeutic modalities and compounds to optimize clinical outcomes for existing…

    An international, peer reviewed, open access journal that focuses on the growing importance of patient preference and adherence throughout the therapeutic continuum. The journal is characterized by the rapid reporting of reviews, original research, modeling and clinical studies across all therapeutic areas. Patient satisfaction, acceptability, quality of life, compliance, persistence and their role in developing new therapeutic modalities and compounds to optimize clinical outcomes for existing disease states are major areas of interest for the journal.
    www.dovepress.com/patient-preference-and-adherence-journal

  • Salford CCG Graphic

    Long Term Conditions Commissioning Strategy Group - Patient Representative

    Salford CCG

    - 1 year 1 month

    Health

    Although there are diverse levels of affluence within the district, Salford is ranked as one of the most deprived local authority areas in England with life expectancy lower than the England average. There are massive health inequalities within Salford with men living in the most deprived areas having over 12 years shorter life expectancy than those from the least deprived areas, and women eight years.

    Our vision is that Salford CCG will commission (buy) high quality services to enable…

    Although there are diverse levels of affluence within the district, Salford is ranked as one of the most deprived local authority areas in England with life expectancy lower than the England average. There are massive health inequalities within Salford with men living in the most deprived areas having over 12 years shorter life expectancy than those from the least deprived areas, and women eight years.

    Our vision is that Salford CCG will commission (buy) high quality services to enable our population to live longer healthier lives.

    We have four main aims:
    2. Reduce health inequalities
    3. Improve healthcare quality
    4. Improve health and wellbeing outcomes

  • NHS England Graphic

    GM Strategic Clinical Senate - Lay Member

    NHS England

    - 2 years

    Health

    Strategic Clinical Networks work in partnership with commissioners (including local government), supporting their decision making and strategic planning, by working across the boundaries of commissioner, provider and voluntary organisations as a vehicle for improvement for patients, carers and the public.

  • NHS Digital Graphic

    Public and Patient Advisor, Data Linkage Advisory Group

    NHS Digital

    - 10 months

    Health

    The data linkage service adds significant value to individual sets of data by combining and matching them at an individual record level in a secure environment.

  • The Aurora Project Graphic

    Founder Member

    The Aurora Project

    - Present 8 years

    Health

    It has been several years since ‘patient centricity’ became an articulated objective for most in the pharma industry. It is now understood that a major organizational and attitudinal shift, possibly even a new business model, is required, to make progress.
    From discussions in late 2015, it became clear that if we were to go anywhere, we needed a global benchmark, to determine where we are now – so we can visualize progress on our upcoming journey.
    Ultimately, our aim is to help move…

    It has been several years since ‘patient centricity’ became an articulated objective for most in the pharma industry. It is now understood that a major organizational and attitudinal shift, possibly even a new business model, is required, to make progress.
    From discussions in late 2015, it became clear that if we were to go anywhere, we needed a global benchmark, to determine where we are now – so we can visualize progress on our upcoming journey.
    Ultimately, our aim is to help move patient centricity from intentions to actions and outcomes.
    We’ve dubbed the project “The Aurora Project” because, just like an aurora or polar light, we will be a natural light that is trying to sufficiently disturb and excite the industry to produce beautiful outcomes of varying colors and complexity.
    What will be the impact of this illumination? Well that’s up to you.

  • BioCity Graphic

    Mentor

    BioCity

    - Present 6 years 11 months

    Science and Technology

    BioCity Group specialises in the creation and development of life science businesses. It provides homes and access to high-end equipment, shared services, training, business support and access to investment for new and growing bioscience businesses.
    Over 200 companies are based in a BioCity Group business incubator, making the BioCity network one of the largest concentrations of life science businesses in the UK. The 91% survival rate of companies at BioCity in Nottingham tangibly…

    BioCity Group specialises in the creation and development of life science businesses. It provides homes and access to high-end equipment, shared services, training, business support and access to investment for new and growing bioscience businesses.
    Over 200 companies are based in a BioCity Group business incubator, making the BioCity network one of the largest concentrations of life science businesses in the UK. The 91% survival rate of companies at BioCity in Nottingham tangibly demonstrates one of the benefits to a company of being located within the BioCity network.

  • MassChallenge Graphic

    Mentor

    MassChallenge

    - 2 years

    Health

    MassChallenge, an annual $1M global startup competition and accelerator program, catalyzes the launch and success of high-growth, high-impact new businesses. As a mentor I support start-ups in the following areas:
    Product/ Service Review
    Partner Relationships
    Channel Marketing
    Patient & Public Engagement
    Advisory Board/ Non Executive/ Chair roles

  • Dotforge Graphic

    Mentor

    Dotforge

    - 3 years

    Health

    dotforge combines investment capital with an intensive mentorship and execution programme to accelerate the growth of ambitious lean startups that have global potential

  • Healthbox Graphic

    Mentor

    Healthbox

    - 4 years 11 months

    Health

    Healthbox will find, nurture and invest in great entrepreneurs and high-impact business ideas that have the potential to scale and impact the future of healthcare delivery. These may be newly formed businesses, SMEs, government-led initiatives, or creative solutions that need support and investment to formalise a business model. Through its intensive three-month programme, Healthbox will help early-stage healthcare technology and technology-enabled startups refine their product offering, gain…

    Healthbox will find, nurture and invest in great entrepreneurs and high-impact business ideas that have the potential to scale and impact the future of healthcare delivery. These may be newly formed businesses, SMEs, government-led initiatives, or creative solutions that need support and investment to formalise a business model. Through its intensive three-month programme, Healthbox will help early-stage healthcare technology and technology-enabled startups refine their product offering, gain market traction and attract customers and investment.

  • Taylor & Francis Group Graphic

    Editorial Board - Journal of Communication in Healthcare (www.tandfonline.com/loi/ycih20)

    Taylor & Francis Group

    - Present 16 years 7 months

    Health

    Journal of Communication in Healthcare: Strategies, Media and Engagement in Global Health is a peer-reviewed journal covering contemporary issues, theories, research findings, evidence-based interventions, and innovation across all areas of health communication research and practice in the fields of the healthcare, public health, and global health. Global in its scope, the Journal examines and engages in relevant topics from a variety of country settings and across professional sectors.

  • Savvy Cooperative Graphic

    Patient Leader

    Savvy Cooperative

    - Present 5 years 10 months

    Health

    We understand what it’s like for patients - because we are them!
    We are patients first, putting patients first. Now that's savvy.

    In healthcare, we do this by giving patients direct ways to share their experiences with health innovators, and advocating that they be fairly compensated for their contributions.
    We empower patients to co-create new solutions, give them a sense of purpose, and help them earn money.

  • WEGO Health Graphic

    Patient Leader

    WEGO Health

    - Present 4 years 5 months

    Health

    WEGO Health is a mission-driven company connecting healthcare with the experience, skills, and insights of patient leaders.

    We connect patient leaders within our network with healthcare companies of all types in order to incorporate the patient perspective and expertise into every stage of the product life cycle.

  • Innovative Medicines Initiative (IMI) Graphic

    Trials@Home - External Stakeholder Panel (ESP) Patient Representative

    Innovative Medicines Initiative (IMI)

    - Present 3 years 9 months

    Health

    Trials@Home is a public-private partnership, funded by the Innovative Medicines Initiative running from 1 September 2019 until 31 August 2024. The overall goal of Trials@Home is to reshape clinical trial design, conduct and operations, by developing and piloting standards, recommendations and tools for the definition and operationalisation of remote decentralised clinical trials (RDCTs) in Europe.

  • EUROPEAN LUNG FOUNDATION Graphic

    Patient Ambassador (Diabetes, Type 2)

    EUROPEAN LUNG FOUNDATION

    - Present 3 years 11 months

    Health

    ELF developed EPAP as it needed patients ready and able to get involved in the future of respiratory healthcare. However, as the skills are common across any disease, ELF worked with partners to ensure that the programme is suitable to anyone living with any chronic condition. This is why EPAP is for everyone, regardless of the condition they are affected by.

  • Innovative Health Initiative (IHI) Graphic

    Patient Pool Member

    Innovative Health Initiative (IHI)

    - Present 1 year 1 month

    Health

    The IHI Patient Pool will strengthen the voice of patients and informal caregivers in a range of IHI activities - www.ihi.europa.eu/about-ihi/who-we-are/ihi-patient-pool

  • Diabetes UK Graphic

    Strategy & Research Advisory Group (SRAG)

    Diabetes UK

    - Present 11 months

    The Science and Research Advisory Group (SRAG) is made up of people living with diabetes, diabetes researchers and healthcare professionals. Members of the group are responsible for working with Diabetes UK to formulate research strategy periodically.
    They review the broad field of diabetes research and make recommendations to the Diabetes UK Board of Trustees on the areas in which the charity should focus its research effort, taking into account the charity’s various constituencies. They…

    The Science and Research Advisory Group (SRAG) is made up of people living with diabetes, diabetes researchers and healthcare professionals. Members of the group are responsible for working with Diabetes UK to formulate research strategy periodically.
    They review the broad field of diabetes research and make recommendations to the Diabetes UK Board of Trustees on the areas in which the charity should focus its research effort, taking into account the charity’s various constituencies. They also promote and encourage research into all aspects of diabetes relevant to the Charity
    www.diabetes.org.uk/research/our-approach-to-research/srag

Publications

  • Putting Measures around the Patient-Focused Approach

    Empowered Patient Podcast

    Mark Duman, the Director of MD Healthcare Consultants in the UK, focuses on patient engagement and digital health strategy, working with established life science companies to actually put patients at the center of their activities.  They are also working with start-ups to scale up their digital health services, navigate healthcare systems, and develop patient engagement strategies. The key to a patient-centric approach is working from the bottom up to find patients through local community and…

    Mark Duman, the Director of MD Healthcare Consultants in the UK, focuses on patient engagement and digital health strategy, working with established life science companies to actually put patients at the center of their activities.  They are also working with start-ups to scale up their digital health services, navigate healthcare systems, and develop patient engagement strategies. The key to a patient-centric approach is working from the bottom up to find patients through local community and faith-based groups and patient advocacy groups.
    Mark explains, "I'm a former pharmacist. I qualified in Aberdeen, in northern Scotland, back in 1990. I had a particular interest at that time in what we call over here pharmacy practice, the idea of supporting patients to take medicines, which, as we know, 50% of them sadly don't take as prescribed. That has been my focus throughout my career. I've worked in the National Health Service, which, as many of you will know, is the British healthcare system that is funded publicly. So I've dispensed medicines and talked to patients, and long story short, about 20 years ago, I got into the whole patient engagement side of things. No decision about us without the patient being included."
     "On the life sciences side, lots of talk about patient engagement and, in many cases, lots of action, but it's often not coordinated. And it happens possibly within silos across even small businesses or small to medium biopharma. In the large ones, it's often even more diluted or siloed. We're being asked to look at where is the patient engagement strategy that joins this together. Where is the operationalization of this so that each part of the function doesn't just say it but truly engages patients and caregivers in the co-creation and co-production of their products and services?" #DigitalHealth #PatientEngagement #Healthcare #PatientFocused

    Other authors
    See publication
  • Patient engagement in Pharma

    NEXT Pharma

    Chat with Dario about patient engagement in Pharma

    Other authors
    See publication
  • Richard Phillips in conversation with Mark Duman (about patient engagement)

    ABHI

    Our latest 'in conversation' features Mark Duman from MD Healthcare, for a discussion on all things patient empowerment and engagement. A passionate advocate for this topic, Mark shares some great insights and best practice examples on how we can elevate the patient voice.

    Other authors
    See publication
  • Optimising medicines vs. supporting people

    Journal of Medicines Optimisation

    Do we focus on medicines or people when discussing treatments?

    See publication
  • Patient engagement strategies

    Pharmaphorum

    Mark takes a helicopter view of patient engagement in a discussion with MSD’s European lead for patient innovation Dr Paul Robinson, that’s moderated by pharmaphorum’s former web editor Catherine Longworth.

    See publication
  • Humans Are Getting in the Way of Digital Health

    MedPage Today

    Digital technologies have transformed the very fabric of our society. The way we talk, move, work, save, and spend have all changed in the face of that innovation. But the way we do healthcare? By and large, it's still painfully analog.

    Other authors
    See publication
  • Engagement matters as much as medicine

    Taylor & Francis Journal of Communication in Healthcare

    What's missing from Covid discussions?

    Other authors
    See publication
  • Digital Domiciliary Care Management Specifications Outline

    Local Government Association/ NHS Digital

    There is a vital need for digital medicines support to improve the health and wellbeing of people being cared for in their own homes. This stakeholder specification has been created to make clear and detailed requirements for a digital solution to technology suppliers. The specification has been co-produced through consultation with homecare providers, council commissioners, pharmacists, technology suppliers, and other strategic health and social care partners. It sets out requirements for…

    There is a vital need for digital medicines support to improve the health and wellbeing of people being cared for in their own homes. This stakeholder specification has been created to make clear and detailed requirements for a digital solution to technology suppliers. The specification has been co-produced through consultation with homecare providers, council commissioners, pharmacists, technology suppliers, and other strategic health and social care partners. It sets out requirements for service users and families, care workers and organisations, pharmacies and health partners, and social care commissioners.

    See publication
  • Information Therapy The Key For Digital Therapeutics

    Ampersand & Ampersand

    Mark Duman, a pharmacist-turned-management consultant and Chief Patient Officer at Ampersand Health, talks about how information therapy and a patient-centred focus can help digital therapeutics solutions like Ampersand’s HealthSuite improve lives.

    See publication
  • Measuring patient engagement: Why and how we need to assess patient centricity

    Health Management

    Key Points
    - Patient engagement is a buzzword that is thrown around a lot, but less frequently acted on with truly positive effects
    - There are many challenges, both in implementing and in measuring the impact of patient engagement strategies
    - Surveying the right people can reveal the success of patient engagement strategies across several key domains

    Other authors
    See publication
  • ‘Smart homes’ could be the future of health

    Healthizmo - Interview

    While bringing together the best of digital technology disruptors and stakeholders, the recent Financial Times Digital Health Summit Europe looked to address some of the burning issues surrounding healthcare and technology.

    See publication
  • How can the healthcare industry turn data into action?

    PatientPower.eu

    4 brief video interviews at Financial Times Digital Health Summit, 2016

    See publication
  • So what is patient centricity?

    Strategic North - navigating healthcare

    In our new series of patient-focused thought pieces, we are delighted to bring you this expert guest blog contributed by Mark Duman.
    Reflecting on Mark’s insights and experience, the Strategic North team share thoughts too.

    See publication
  • A holistic approach to patient care in pulmonary arterial hypertension

    Actelion

    A report developed by Actelion Pharmaceuticals Ltd in consultation with an international expert steering group

    Other authors
    • Facilitator & Foreword
    See publication
  • Working together, delivering for patients A guide to collaboration between charities and pharmaceutical companies in the UK

    National Voices/ Association of the British Pharmaceutical Industry

    Mark Duman & Jules Gaughan - Contributors via MD Healthcare
    The guide was developed by the ABPI and National Voices, its development was overseen by a steering group with representatives from both pharmaceutical companies and the charity sector. The main purpose of this guide is to support collaboration between charities and pharmaceutical companies, to ensure that any collaboration is beneficial to both parties and beneficial to patients. Although guidance and regulation, covering…

    Mark Duman & Jules Gaughan - Contributors via MD Healthcare
    The guide was developed by the ABPI and National Voices, its development was overseen by a steering group with representatives from both pharmaceutical companies and the charity sector. The main purpose of this guide is to support collaboration between charities and pharmaceutical companies, to ensure that any collaboration is beneficial to both parties and beneficial to patients. Although guidance and regulation, covering collaboration between pharmaceutical companies and charities, already exists, there is nothing which addresses both sectors together or fully promotes mutual understanding.

    Other authors
    See publication
  • “I have the next killer Health App”

    Salus Digital

    10 top tips when developing apps/ solutions for patients

    See publication
  • Only patients can close the NHS funding gap

    Commissioning Excellent/ Primary Care Commissioning

    Commissioners spend most of their energy and devote the lion’s share of their programme budgets to providing services to address ill health. In a cash-strapped NHS with spiralling demand, this approach is no longer sustainable.

    See publication
  • Is Knowledge Power? Using information and support to empower patients

    Patient Information Forum (PiF) with mhp communications

    This report explores whether current approaches are enough to support people to
    truly be equal partners in their own care, and whether information provision, and its use
    through, for example, constructive, supportive patient-‘professional’ dialogue, needs to evolve
    in order to deliver the aspirational ideals to empower patients. As users of and payers for
    one of the leading health systems in the world, we should expect nothing less.

    Other authors
    See publication
  • Better measures needed on the impact of health communication

    Journal of Communication in Healthcare Volume 8, Issue 1 (March, 2015), pp. 3-4

  • Use or lose it: tackling the thorny issue of adherence

    PharmaTimes Magazine

    Did you take you medicines today?
    Simple question, simple answer. Or is it?
    NOTE: Contributor (not author)

    Other authors
    • katherine meggett
    See publication
  • The engaging expert

    The Pharmaceutical Journal

    Pharmacist Mark Duman helps organisations improve their services and products by involving patients and the public. He advocates sharing knowledge with patients to help them make informed choices about their healthcare.

    See publication
  • Practice what you preach

    PharmaTimes

    Is pharma walking the walk when it comes to patient centricity?

    See publication
  • HSJ Roundtable: How to tackle the workforce planning issue

    Health Service Journal (HSJ)

    HSJ hosted a roundtable, sponsored by HCL Workforce Solutions, to explore whether the NHS workforce is able to deal with the present and future demands placed upon it. Jennifer Trueland reports

    See publication
  • Patients can be part of the solution, we just need to let them in

    The Health Foundation

    The idea of consumers being at the centre of services is a simple idea that’s illustrated across retail, travel, finance and many other sectors. However health professionals – clinicians and managers – are still struggling to recognise and unleash the full value that patients, as informed active consumers, can bring to the NHS.

    See publication
  • Making ‘medicines-taking’ a better experience

    NHS England Bulletin for CCGs: Issue 57

    Report presenting the outcomes and supporting evidence arising from a one-day facilitated workshop on 21st November 2013. The aim of the workshop, and this report, is to inform NHS England’s forthcoming Medicines Optimisation (MO) Strategy ensuring it starts where it aims to finish i.e. to help patients, and the system, get better outcomes from medicines.

    Other authors
    • Clare Howard
    • Amy Wynne-Jones
    See publication
  • Patient engagement – we need to live it, not talk it

    The Health Foundation

    Patient engagement is much talked about. Thankfully.
    However, casting my mind back 20 years when organising The King’s Fund’s Promoting Patient Choice conference, I recall having no difficulty in finding two doctors to get up in front of the 300+ audience and argue that ‘patients should do what they’re told’...

    See publication
  • Report on the Independent Commission on Whole Person Care

    Independent Commission on Whole Person Care/ Sir John Oldham

    Mark Duman - Contributor
    What people with multiple conditions and complex needs say is: ‘I want you to care for the whole of me, and act as one team’. This is what we require commissioners and providers of health and social care to achieve: the needs of one person addressed by people acting as one team, from organisations behaving as one system. This starts with a conversation – listening to what you really want and takes account of your physical health, mental health, functional needs…

    Mark Duman - Contributor
    What people with multiple conditions and complex needs say is: ‘I want you to care for the whole of me, and act as one team’. This is what we require commissioners and providers of health and social care to achieve: the needs of one person addressed by people acting as one team, from organisations behaving as one system. This starts with a conversation – listening to what you really want and takes account of your physical health, mental health, functional needs, environment and degree of empowerment.

    See publication
  • Unlocking the power of information

    {Smart Guides} to ENGAGEMENT For better commissioning

    Part of the Smart Guides to Engagement series, this guide helps clinical commissioning groups (CCGs) and service providers understand how information is the foundation for effective engagement with patients so that they can become partners in decision-making about their own health and care. It describes what works and points to sources of help to achieve success.
    This guide should be read with Engaging With Individual Patients, which can be accessed with the rest of the Smart Guides at…

    Part of the Smart Guides to Engagement series, this guide helps clinical commissioning groups (CCGs) and service providers understand how information is the foundation for effective engagement with patients so that they can become partners in decision-making about their own health and care. It describes what works and points to sources of help to achieve success.
    This guide should be read with Engaging With Individual Patients, which can be accessed with the rest of the Smart Guides at www.networks.nhs.uk/nhs-networks/smart-guides

    See publication
  • In the know: raising the profile of patient information

    Health Service Journal (HSJ)

    Mark Duman and Sarah Smith look at why patient health information is still seen as ‘nice to have’ when it should really be ‘must do’

    Other authors
    See publication
  • The Case for Information

    Patient Information Forum

    Carol Grant and Paul Treadgold from Grant Riches authored the PiF report Making the Case for Information which brings together the evidence for investing in high quality health information for patients and the public.

    The evidence shows that providing high quality health information is beneficial. It has a positive impact on service utilisation and health costs, patients’ experience of healthcare and patients’ health behaviour and status. Providing access to quality health information…

    Carol Grant and Paul Treadgold from Grant Riches authored the PiF report Making the Case for Information which brings together the evidence for investing in high quality health information for patients and the public.

    The evidence shows that providing high quality health information is beneficial. It has a positive impact on service utilisation and health costs, patients’ experience of healthcare and patients’ health behaviour and status. Providing access to quality health information and support is crucial to unlocking what has been termed the ‘blockbuster drug’ of patient engagement. Patient engagement is vital to help people manage their health, make informed decisions about their healthcare, and mitigate financial pressure on the health service.

    Evidence from the review points to the most effective ways of providing consumer health information and maximising its impacts, including information tailored to the individual which addresses health literacy needs and which is supported by health or information professionals. The report, concludes that there are good business reasons to justify the need for commissioners and providers to invest more resource (time, money and training) in health information provision and support.

    See publication
  • What is the attitude of the patient? Information overload or lack of interest?

    The Faculty of Pharmaceutical Medicine - Annual Symposium

    Why does adherence to medicines matter?

    See publication
  • Information: first line therapy?

    Atlantis Healthcare

    A patient-centric approach to communicating with patients is a vital step in building understanding and changing behaviour.

    See publication
  • Networking skills

    business:life magazine

    Sharpen up your networking skills to make valuable new business contacts

    See publication
  • The state of consumer health information: an overview

    Health Information & Libraries Journal

    Abstract
    Background:  Consumer health information is becoming increasingly important and health policy in the UK is beginning to reflect this. This has implications for information producers, providers and users, with the move towards a more patient-centred health service.

    Objectives:  This review aims to provide a broad overview of the current state of consumer health information in the UK. It examines the changing roles of information producers, providers and users, exploring the…

    Abstract
    Background:  Consumer health information is becoming increasingly important and health policy in the UK is beginning to reflect this. This has implications for information producers, providers and users, with the move towards a more patient-centred health service.

    Objectives:  This review aims to provide a broad overview of the current state of consumer health information in the UK. It examines the changing roles of information producers, providers and users, exploring the impact of health literacy and new technologies. It features some of the current library and consumer health information projects taking place in the UK and discusses the role that libraries may play in the future.

    Methods:  The article focuses on consumer health information in a policy context. It is based on the experiences of the authors' work for the Patient Information Forum and knowledge of consumer health information. A number of library and information professionals were consulted regarding the library and information projects.

    Conclusions:  Communication between health professionals and patients, and between health educators and the public, is key in order for consumer health information to have the ability to improve health outcomes. Further, especially local, investment into the production, distribution and delivery of consumer health information is recommended.

    Other authors
    See publication
  • Nine Big Questions about Behaviour Change

    Commissioned by the Department for Transport

    Other authors
    • Simon Christmas (Principal Author) [Mark Duman, Contributor]
    See publication
  • Producing Patient Information

    The King's Fund

    How to research, develop and produce effective information resources

    See publication

Honors & Awards

  • Future50 - Patient Leader Category

    HIMSS

    The HIMSS Future50 is who we should look to for the future of healthcare today. They influence the potential of digital health to improve healthcare for all of us. The Future50 community will be encouraged to share expertise, collaborate over borders and foster innovation both individually and as a group.
    www.himss.eu/communities/himss-future50-international

  • Pharmacy Practice Award

    South East Pharmaceutical Industry Group

    PharmAssist: Innovation in patient medicines education

  • Zeneca Pharma Travel Fellowship

    AstraZeneca

    PharmAssist: Innovation in patient medicines education

  • Pharmaceutical Care Award - Hospital Section

    Royal Pharmaceutical Society

    PharmAssist: Innovation in patient medicines education

  • Merrel Dow Final Year Pharmacy Practice

    Robert Gordon University

Organizations

  • Digital Health & Care Alliance (DHACA)

    Member

    - Present
  • Royal Pharmaceutical Society

    Member

    - Present
  • Royal Society of Medicine

    Member

    -
  • Drug Industry Association (DIA)

    Patient Member

    -

    DIA fosters innovation to improve health and well-being worldwide by: Providing invaluable forums to exchange vital information and discuss current issues related to healthcare products, technologies, and services; Delivering customized learning experiences; Building, maintaining, and facilitating trusted relationships with and among individuals and organizations that drive and share DIA values and mandates; and Offering a multidisciplinary neutral environment, respected globally for integrity…

    DIA fosters innovation to improve health and well-being worldwide by: Providing invaluable forums to exchange vital information and discuss current issues related to healthcare products, technologies, and services; Delivering customized learning experiences; Building, maintaining, and facilitating trusted relationships with and among individuals and organizations that drive and share DIA values and mandates; and Offering a multidisciplinary neutral environment, respected globally for integrity and relevancy.

Recommendations received

More activity by Mark

View Mark’s full profile

  • See who you know in common
  • Get introduced
  • Contact Mark directly
Join to view full profile

Other similar profiles

Explore collaborative articles

We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.

Explore More

Add new skills with these courses